Details der Publikation - Treatment of severe COVID-19 with angiotensin-(1-7)

Medienart:	Klinische Studie

Erscheinungsjahr:	2023
Erschienen:	2023

Enthalten in:	WHO International Clinical Trials Registry Platform - (2023) vom: 29. Mai Zur Gesamtaufnahme - year:2023

Sprache:	Englisch

Links:	Volltext [kostenfrei]

Themen:	610 Medical Condition: Severe Infection with Sara-CoV-2;C01.925.782.600.550.200 Phase: Phase 1/Phase 2 Recruitment Status: Recruiting Study Type: Interventional

Anmerkungen:	WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 05-08-2020, Last updated: 2023-06-05

ICTRP ID:	RBR-35734p

Förderinstitution / Projekttitel:

PPN (Katalog-ID):	WHO006940471


LEADER	01000caa a22002652 4500
001	WHO006940471
003	DE-627
005	20230605131204.0
007	cr uuu---uuuuu
008	210507s2023 xx \|\|\|\|\|o 00\| \|\|eng c
035			\|a (DE-627)WHO006940471
035			\|a (UBBS_Klinische_Studien_WHO)RBR-35734p
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
245	1	0	\|a Treatment of severe COVID-19 with angiotensin-(1-7) \|b Randomized clinical trial phase I/II for the use of angiotensin-(1-7) in the treatment of severe infection by Sara-CoV-2
264		1	\|c 2023
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 05-08-2020, Last updated: 2023-06-05
650		4	\|a Medical Condition: Severe Infection with Sara-CoV-2;C01.925.782.600.550.200
650		4	\|a Study Type: Interventional
650		4	\|a Phase: Phase 1/Phase 2
650		4	\|a Recruitment Status: Recruiting
650		4	\|a 610
773	0	8	\|i Enthalten in \|t WHO International Clinical Trials Registry Platform \|g (2023) vom: 29. Mai
773	1	8	\|g year:2023 \|g day:29 \|g month:05
856	4	0	\|u http://ensaiosclinicos.gov.br/rg/RBR-35734p \|z kostenfrei \|3 Volltext
912			\|a GBV_CTG
951			\|a AR
952			\|j 2023 \|b 29 \|c 05